{"id":"W4414606164","doi":"10.1038/s41467-025-63579-9","title":"Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Pharmacokinetics; Adverse effect; Clinical trial; Drug; Immunotherapy; Pharmacodynamics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001156557,0.0009730634,0.001142783,0.000202434,0.0002453241,0.0008618716,0.0003929894,0.001009527,0.002177782],"category_scores_gemma":[0.0007168521,0.0002906019,0.0008131182,0.0002244534,0.0004834083,0.0006689312,0.0002193203,0.001661741,0.0005576039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005947208,"about_ca_system_score_gemma":0.0008089854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002968201,"about_ca_topic_score_gemma":0.0005672716,"domain_scores_codex":[0.9997538,0.0001132287,0.00001261918,0.00003892508,0.0000249634,0.00005648468],"domain_scores_gemma":[0.9995708,0.00009912065,0.00008951953,0.00002961264,0.00002758741,0.0001833024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7278467,0.03082186,0.00736854,0.001248893,0.0009176294,0.0005473507,0.00046033,0.003449146,0.0568743,0.0005054724,0.004130791,0.1658289],"study_design_scores_gemma":[0.5730081,0.4083965,0.008198553,0.00005423423,0.000242133,0.0003837536,0.00004620805,0.002017989,0.004581732,0.000273262,0.002771992,0.00002551002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934088,0.002762959,0.0005557835,0.0003929794,0.00009874202,0.001143963,0.0005514865,0.00007858936,0.001006678],"genre_scores_gemma":[0.993782,0.001469521,0.000907619,0.0005366178,0.0001122155,0.0009641051,0.0009324998,0.00001368847,0.001281696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002177782,"threshold_uncertainty_score":0.007285357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01866290995679088,"score_gpt":0.3753721925454597,"score_spread":0.3567092825886689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}